Retrospective Observation of Low-Dose Rituximab Treatment in Chinese Patients With Neuromyelitis Optica Spectrum Disorders in a Real-World Setting.

Regarding different induction and maintenance regimens, IND-B (375-mg/m 2 /week infusions for 1 month) and M-A (fixed time-point infusions of 1000 mg every 6 months) may be less effective strategies as both the ARR and the time to the first relapse analyses showed a trend toward increased disease activity with IND-B and M-A.

also in 53,322 other papers